Skip to main content
logo
Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
37.72
-1.34 (-3.43%)
At close: Mar 3, 2026, 4:00 PM EST
38.20
+0.48 (1.27%)
After-hours: Mar 3, 2026, 7:18 PM EST

Soleno Therapeutics Revenue

In the year 2025, Soleno Therapeutics had annual revenue of $190.41M. Soleno Therapeutics had revenue of $91.73M in the quarter ending December 31, 2025.

Revenue (ttm)
$190.41M
Revenue Growth
n/a
P/S Ratio
10.23
Revenue / Employee
$1,252,664
Employees
152
Market Cap
1.95B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025190.41M--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ultragenyx Pharmaceutical673.00M
Zai Lab460.16M
Aurinia Pharmaceuticals283.06M
Syndax Pharmaceuticals172.35M
Recursion Pharmaceuticals74.68M
Mesoblast65.38M
Nektar Therapeutics62.60M
Ascentage Pharma Group International54.52M
Revenue Rankings

SLNO News

More News